India - English - Central Drugs Standard Control Organization

devi form. - amikacin - inj - 100/250;mg - v.

India - English - Central Drugs Standard Control Organization

devi form. - amikacin - inj - 500mg - v.

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

bioveta a.s., czech republic - natrii citras anhydricus, natrii acetas anhydricus, natrii propionas, kalii chloridum, natrii chloridum, kalii dihydrogenophosphas - oral powder - 1.36.4.68.2.98.1.92.3.28 g

United States - English - NLM (National Library of Medicine)

silver star brands - potassium sulfate (unii: 1k573lc5tv) (potassium cation - unii:295o53k152), ferrosoferric phosphate (unii: 91gqh8i5f7) (ferrosoferric phosphate - unii:91gqh8i5f7), sodium phosphate, dibasic (unii: gr686lba74) (phosphate ion - unii:nk08v8k8hr) - uses*: homeopathic remedy for relieving symptoms of bladder problems. *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated. relieves burning sensation frequent urination & urgency.

Singapore - English - HSA (Health Sciences Authority)

baxter healthcare (asia) pte ltd - cardiovascular - intended for repair of pericardial structures and for use as a prosthesis for the surgical repair of soft tissue deficiencies, which include: defects of the abdominal and thoracis wall, hernias (including diaphragmatic, femoral, incisional, inguinal, lumbar, paracolostomy, scrotal, and umbilical) and intracardiac and great vessel repair.

Malta - English - Medicines Authority

alembic pharmaceuticals europe limited palazzo pietro stiges, 103, strait street, valletta vlt 1436, malta - celecoxib - hard capsule - celecoxib 100 mg - antiinflammatory and antirheumatic products

Malta - English - Medicines Authority

alembic pharmaceuticals europe limited palazzo pietro stiges, 103, strait street, valletta vlt 1436, malta - celecoxib - hard capsule - celecoxib 200 mg - antiinflammatory and antirheumatic products

European Union - English - EMA (European Medicines Agency)

astellas pharma gmbh - tacrolimus - dermatitis, atopic - other dermatological preparations - treatment of moderate to severe atopic dermatitis in adults who are not adequately responsive to or are intolerant of conventional therapies such as topical corticosteroids. treatment of moderate to severe atopic dermatitis in children (2 years of age and above) who failed to respond adequately to conventional therapies such as topical corticosteroids.maintenance treatment of moderate to severe atopic dermatitis for the prevention of flares and the prolongation of flare-free intervals in patients experiencing a high frequency of disease exacerbations (i.e. occurring 4 or more times per year) who have had an initial response to a maximum of 6 weeks treatment of twice daily tacrolimus ointment (lesions cleared, almost cleared or mildly affected).

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

krka d.d. - liquid aqueous cowslip root extract, liquid aqueous garden thyme herb extract - syrup - 1030mg/5ml+ 2060mg/5ml